• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

The 14th US-Japan Cellular and Gene Therapy Conference

Induced Pluripotent Stem Cells (iPS): Derivation and Characterization

Natcher Conference Center
Building 45, Balcony A and B, National Institutes of Health
Bethesda, Maryland 20892

Thursday, February 24, 2011

The conference is jointly supported by the Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration (FDA) and the Ministry of Education, Culture, Sports, Science and Technology, Japan under the US-Japan Cooperative Research Program. The goal of this conference is to exchange ideas on cutting edge areas of biomedical research and to enhance opportunities for collaborations among scientists from the US and Japan. The scientific theme of our joint annual meetings has been diverse. We have invited speakers from Japan and the US to discuss advances in this emerging field of research and highlight FDA's regulations in this cutting-edge field of biomedical research.

Seating is limited to 200 attendees and is on a first-come-first-served basis. No prior registration is required. For more information, please contact Dr. Syed R Husain by e-mailing syed.husain@fda.hhs.gov or phone at (301) 827-0475.